HomeNLSPW • NASDAQ
add
NLS Pharmaceutics Ltd. Wt
Previous close
$0.015
Day range
$0.012 - $0.030
Year range
$0.00090 - $0.070
Market cap
7.43M USD
Avg Volume
41.06K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 889.61K | -13.36% |
Net income | -1.11M | -9.08% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -888.62K | 13.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.07M | 455.83% |
Total assets | 4.34M | 263.45% |
Total liabilities | 1.46M | -86.09% |
Total equity | 2.88M | — |
Shares outstanding | 4.15M | — |
Price to book | 0.02 | — |
Return on assets | -51.27% | — |
Return on capital | -77.16% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.11M | -9.08% |
Cash from operations | -1.04M | -35.50% |
Cash from investing | — | — |
Cash from financing | 1.74M | 193.59% |
Net change in cash | 703.49K | 507.91% |
Free cash flow | -532.01K | 16.45% |
About
Founded
2015
Website
Employees
1
